Filing Details
Neuphoria Therapeutics Inc. (NASDAQ:NEUP) filed a Form 8-K with the Securities and Exchange Commission on October 23, 2026, disclosing a material event.
8k filedNASDAQ:NEUP
Neuphoria Therapeutics Inc. (NEUP) Reports Material Event to SEC
Neuphoria Therapeutics Inc. (NASDAQ:NEUP) filed a Form 8-K with the Securities and Exchange Commission on October 23, 2026, disclosing a material event.
At publication ·
What changed
Neuphoria Therapeutics Inc. (NASDAQ:NEUP) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Neuphoria Therapeutics Inc. filed a Form 8-K with the SEC on October 23, 2026, disclosing a material event but the specific nature was not detailed in this announcement.
- The company's stock trades at $3.44 per share with a market capitalization of $7.4 million.
- Form 8-K filings report material events such as leadership changes, agreements, acquisitions, or asset sales that shareholders should know about between regular reports.
Market Context
Neuphoria Therapeutics Inc.'s stock currently trades at $3.44 with a market capitalization of $7.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Neuphoria Therapeutics Inc.'s stock.
All SEC filings for Neuphoria Therapeutics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NEUP Stock Page
Frequently Asked Questions
Where can I read NEUP's SEC filings?
Browse all filings on our NEUP SEC filings page.
What types of SEC filings does Neuphoria Therapeutics Inc. file?
Public companies like Neuphoria Therapeutics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.